Table 1.
Group | Emax (g) | EC50 (nmol/l) |
Control | 1.86 ± 0.04 | 8.55 ± 0.08 |
LPS shock | 0.95 ± 0.01a | 13.49 ± 0.06a |
Ala-Gln+LPS | 1.27 ± 0.02a,b | 10.15 ± 0.04a,b |
Data are shown as mean ± standard deviation (n = 8 in each group). aP < 0.05 versus the control group; bP < 0.05 versus the LPS shock group. Ala-Gln+LPS, alanyl-glutamine dipeptide + lipopolysaccharide shock; Emax, maximum efficacy; EC50, median effective dose; LPS, lipopolysaccharide.